ArticleNanomedicine (London, England)2025
Synthesis and biocompatibility studies of 2D molybdenum carbide (MXene) nanosheets and their potential uses.
Article in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- MoNanoscale advances · 2026Article
- Green Synthesis of MXenes: Sustainable Pathways, Enhanced Properties, and Application Prospects.Chemical record (New York, N.Y.) · 2026Review
- Critical Assessment of Intrinsic Antibacterial Properties and Photothermal Therapy Potential of MXene Nanosheets.ACS applied nano materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThis study aims to evaluate the biocompatibility and explore the potential biomedical applications of two-dimensional (2D) molybdenum carbide (Mo₂CTх) MXene.
methodsMo₂CTх MXene was synthesized by etching Mo₂Ga₂C using a Minimally Intensive Layer Delamination (MILD) method combined with hydrofluoric acid (HF). The structural and functional characteristics of the resulting material were characterized using UV-Vis, FT-IR, XRD, and FESEM. Antimicrobial activity was assessed against Staphylococcus aureus and Shigella sonnei, while biocompatibility was evaluated through in vitro testing on A549 lung epithelial cells and in vivo analysis using zebrafish embryos.
resultsUV-Vis analysis showed characteristic absorption peaks at 220 nm and 550 nm. FT-IR confirmed the presence of surface functional groups. XRD results indicated high phase purity, and FESEM revealed a typical layered 2D morphology. Antimicrobial testing demonstrated a concentration-dependent response, with stronger inhibitory effects against S. aureus than S. sonnei. Biocompatibility studies showed high cell viability at low concentrations and no significant toxicity or morphological abnormalities in zebrafish embryos.
conclusionMo₂CTх MXene exhibits strong antimicrobial activity alongside excellent biocompatibility, highlighting its promise for biomedical applications. However, further studies focusing on long-term safety and functional surface modifications are needed to support its use in targeted therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.